In part 5 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the importance of knowing the stages of type 1 diabetes.
Carla Greenbaum, MD is Director of the Diabetes Research Program at Benaroya Research Institute at Virginia Mason in Seattle, WA.
Transcript of this video segment:
Steve Freed: So, what are the stages of type 1 diabetes? And why does it matter?
Carla Greenbaum: Yeah. So I talked a little bit about that the first stage is when you have multiple antibodies and normal glucose and you feel fine. The second, multiple antibodies and abnormal glucose, and stage 3 is new onset. It matters because when we’re doing therapies there, we are treating disease and not preventing the disease. We’re preventing further manifestation of the disease, but we’re not giving therapies to healthy people. We’re giving therapies to people who are already ill.